Try the modernized beta website. Learn more about the modernization effort.
Working… Menu
Trial record 6 of 22 for:    TNX-102

A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participants With PTSD (RECOVERY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03841773
Recruitment Status : Terminated (Interim Analysis results)
First Posted : February 15, 2019
Last Update Posted : February 11, 2021
Information provided by (Responsible Party):
Tonix Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : April 24, 2020
Actual Study Completion Date : April 24, 2020